Found 4 matching trials
Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults PHASE1 The purpose of the study is to determine the safety of and immune response ...
Show More Location
San Francisco Vaccine and Prevention CRS
Learn More & Join Trial
Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients PHASE1 HIV-1-infected patients who have been treated with anti-HIV drugs for a lon...
Show More Location
University of Colorado, Health Science Center
Learn More & Join Trial
A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) PHASE1 The use of a Bioject 2000 needle free injection device (NFID) and a compres...
Show More Location
AIDS Research Alliance
Learn More & Join Trial
Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults PHASE1 The purpose of this study is to test the safety of an HIV DNA vaccine (EP H...
Show More Location
Brigham and Women's Hosp. CRS
Learn More & Join Trial